US EditionPublished • loading... • Updated
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Summary by The Motley Fool
1 Articles
1 Articles
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Key PointsFCPM III Services bought 1,489,096 RAPT shares last quarter.The quarter-end position value rose by $53.22 million, reflecting both trading and stock price movement.Post-trade, the fund held 1,833,333 shares valued at $62.09 million.10 stocks we like better than Rapt Therapeutics › On February 17, 2026, FCPM III Services B.V. disclosed a buy of 1,489,096 RAPT Therapeutics (NASDAQ:RAPT) shares, an estimated $46.24 million trade based on …
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
